IP Library Granted Patent US 11,241,254
Granted Patent B2
US 11,241,254 · App. 16/367,068 · Granted Feb 8, 2022

Uterine hemorrhage controlling system and method

Inventors: Alexander James Norred (San Luis Obispo, CA); Davis Reed Carlin (Sammamish, WA); George Cochran Harper (Laguna Niguel, CA); David C. Lagrew, Jr. (Irvine, CA); Amelia Michele Degenkolb (San Luis Obispo, CA)
Assignee: Alydia Health, Inc.
A61B17/42A61B17/1204A61B17/12136A61B2017/306A61B2217/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,241,254
App. No.
16/367,068
Granted
Feb 8, 2022
Kind
B2
Abstract

An embodiment of a uterine hemorrhage controlling system comprises a suction module including a suction end coupleable to a pump by a connecting tube, and a sealing module coupled to the suction module. The system may further comprise the pump and a filter coupled to the suction module. A uterine hemorrhage controlling method comprises: shielding a suction module that has been delivered into a uterus; sealing an entrance into the uterus while the suction module is situated within the uterus; applying a negative pressure within the uterus upon activation of a pump; and maintaining the negative pressure within the uterus to induce uterine contraction. The method may further comprise delivering the suction module into the uterus; transmitting bodily fluids, out of the uterus through the suction module, and filtering the bodily fluids.

Claims (28)

1. A uterine hemorrhage controlling system comprising:

a connecting tube comprising a lumen and further comprising a proximal portion configured to connect to a pump;

a suction module configured for insertion into a uterus, the suction module comprising a flexible suction tube configured to form a loop,

a set of openings defined along a medial surface of the loop of the flexible suction tube, wherein the set of openings is configured to be medially oriented away from an interior surface of the uterus when the suction module is delivered into the uterus, and configured to fluidly connect to the lumen of the connecting tube, and wherein activation of the pump generates a negative pressure at the set of openings to induce uterine contraction about the loop without obstruction of the set of openings;

a shield coupled with the flexible suction tube and configured to limit obstruction of the set of openings; and

a seal coupled to the connecting tube between the suction module and the pump and operable in a first configuration, the seal configured to hermetically seal an entrance to the uterus to maintain a negative pressure within the uterus in the first configuration, thereby closing exposed arterioles of the uterus in order to control uterine hemorrhaging, wherein the seal comprises a balloon configured to have an expanded configuration, as the first configuration, and a contracted configuration, as a second configuration.

2. The system of claim 1 , wherein the shield is configured to flank a portion of the flexible suction tube and to diverge outward proximal to at least one opening of the set of openings.

3. The system of claim 1 , wherein the balloon surrounds the connecting tube at a location between the pump and the suction module and is substantially concentric with the connecting tube.

4. The system of claim 1 , wherein the expanded configuration of the balloon produces a balloon diameter substantially between 5 and 14 cm.

5. The system of claim 1 , wherein the balloon has a volumetric capacity of up to 300 mL and is configured to withstand an internal pressure of at least 5 psi.

6. The system of claim 1 , wherein an axial deformation of the seal produces a sealing configuration that blocks an entrance to the uterus.

7. The system of claim 1 , wherein the balloon comprises an opening configured to receive at least one of a gas and a fluid that expands the balloon into the expanded configuration.

8. The system of claim 7 , wherein the opening is fluidly coupled to a delivery conduit that delivers at least one of the gas and the fluid into the balloon, and wherein the delivery conduit comprises a delivery tube that runs parallel with the connecting tube.

9. The system of claim 1 , wherein the flexible suction tube is configured to reversibly deform for delivery to the uterus.

10. The system of claim 1 , wherein the shield is flexible.

11. A uterine hemorrhage controlling system comprising:

a connecting tube comprising a lumen and further comprising a proximal portion configured to connect to a pump;

a suction module configured for insertion into a uterus, the suction module comprising a flexible suction tube configured to form a loop,

a set of openings defined along a medial surface of the loop of the flexible suction tube, wherein the set of openings is configured to be medially oriented away from an interior surface of the uterus when the suction module is delivered into the uterus, and configured to fluidly connect to the lumen of the connecting tube, and wherein activation of the pump generates a negative pressure at the set of openings to induce uterine contraction about the loop without obstruction of the set of openings;

a shield coupled with the flexible suction tube and configured to limit obstruction of the set of openings; and

a seal coupled to the connecting tube between the suction module and the pump and operable in an expanded configuration, the seal configured to hermetically seal an entrance to the uterus to maintain a negative pressure within the uterus in the expanded configuration, thereby closing exposed arterioles of the uterus in order to control uterine hemorrhaging,

wherein the seal comprises a balloon configured to have the expanded configuration and a contracted configuration, the balloon including an opening fluidly coupled to a delivery conduit that runs parallel with the connecting tube and that delivers at least one of a gas and a fluid into the balloon that expands the balloon into the expanded configuration.

12. The system of claim 11 , wherein the balloon substantially surrounds the connecting tube at a location between the pump and the suction module and is substantially concentric with the connecting tube.

13. The system of claim 11 , wherein the expanded configuration of the balloon produces a balloon diameter from 5 to 14 cm, and wherein the balloon has a volumetric capacity of up to 300 mL to substantially seal the entrance to the uterus.

14. The system of claim 11 , wherein the shield is configured to flank a portion of the flexible suction tube and to diverge outward proximal to at least one opening of the set of openings.

15. The system of claim 11 , wherein an axial deformation of the seal produces a sealing configuration that blocks an entrance to the uterus.

16. The system of claim 11 , wherein the flexible suction tube is configured to reversibly deform for delivery to the uterus.

17. The system of claim 11 , wherein the shield is flexible.

Assignments (13)
SECURITY INTEREST Recorded Feb 27, 2026
From: ALYDIA HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073924/0283 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073647/0789 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION), AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073648/0021 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION), AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073648/0252 →
RELEASE OF SECURITY INTEREST Recorded Jan 30, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: ALYDIA HEALTH, INC.
Reel/Frame 073648/0473 →
SECURITY INTEREST Recorded May 29, 2024
From: ALYDIA HEALTH, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 067545/0844 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT (CREDIT AGREEMENT) Recorded Mar 11, 2022
From: ALYDIA HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 059710/0557 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT (DOLLAR NOTES) Recorded Mar 11, 2022
From: ALYDIA HEALTH, INC.
To: U.S. BANK, NATIONAL ASSOCIATION , AS COLLATERAL AGENT
Reel/Frame 059710/0570 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT (EURO NOTES) Recorded Mar 11, 2022
From: ALYDIA HEALTH, INC.
To: U.S. BANK, NATIONAL ASSOCIATION , AS COLLATERAL AGENT
Reel/Frame 059710/0612 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2021
From: NORRED, ALEXANDER; CARLIN, DAVIS; HARPER, GEORGE C.; LAGREW, DAVID C., JR.
To: INPRESS TECHNOLOGIES
Reel/Frame 056922/0516 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2021
From: INPRESS TECHNOLOGIES
To: INPRESS TECHNOLOGIES, INC.
Reel/Frame 056922/0588 →
CHANGE OF NAME Recorded Jul 20, 2021
From: INPRESS TECHNOLOGIES, INC.
To: ALYDIA HEALTH, INC.
Reel/Frame 056922/0611 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2021
From: DEGENKOLB, AMELIA MICHELE
To: ALYDIA HEALTH, INC.
Reel/Frame 056922/0669 →
Continuity (4)
Continuation 16035543 · Jul 13, 2018
Continuation 13827579 · Mar 14, 2013
Continuation In Part 13420871 · Mar 15, 2012
Related Publication 20190216504A1 · Jul 18, 2019
Cited By (3)
US 12,280,202 US 12,508,053 US 12,616,503